Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic analysis of senescent cells and liver treated with Cardiac glycosides

ABSTRACT: Transcriptomic analysis of senescent cells and liver treated with Cardiac glycosides

PROVIDER: PRJNA503411 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8145410.fastq.gz	Fastqsanger.gz
	SRR8145420.fastq.gz	Fastqsanger.gz
	SRR8145430.fastq.gz	Fastqsanger.gz
	SRR8145440.fastq.gz	Fastqsanger.gz
	SRR8145450.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 54

Similar Datasets

Transcriptomic analysis of senescent cells treated with Cardiac glycosides

Project description:Transcriptomic analysis of senescent cells treated with Cardiac glycosides

| PRJNA503415 | ENA

Transcriptome analysis of human iPSC-neurons treated with cardiac glycosides

Project description:Transcriptome analysis of human iPSC-neurons treated with cardiac glycosides

| PRJNA949526 | ENA

Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells

Project description:Prostate cancer is the most common cancer in men and cardiac glycosides inhibit prostate cancer cell proliferation. In order to investigate the mechanism by which cardiac glycosides inhibit prostate cancer cells, we observed genome-wide RNA expression in prostate cancer LNCaP-abl cells, hormone resistant cells, after the cardiac glycoside treatment using RNA-Seq. In addition, we profiled LNCaP-abl cells after androgen receptor (AR) knockdown to observe whether cardiac glycoside effect on RNA expression is similar to that of AR knockdown. Observation of three cardioglycosides, Digoxin, Peruvoside and Strophanthidin, and AR knockdown regulated RNA expression in LNCaP-abl with RNA-Seq (each triplicates)

2012-04-03 | E-GEOD-35126 | biostudies-arrayexpress

Proteomics data of DMC-treated senescent cells

Project description:Three groups of cells, including the control group, the senescent cells group, and the DMC-treated senescent cells group

2023-11-23 | PXD047192 |

Transcriptome analysis of human iPSC-neurons treated with cardiac glycosides

Project description:To investigate the molecular mechanisms of cardiac glycosides’ neuroprotection, we profiled transcriptomes of human iPSC-neurons after 72h of treatment with increasing doses of digoxin, oleandrin, proscillaridin A or vehicle alone (0.1% DMSO) using RNA sequencing.

2023-10-19 | GSE228348 | GEO

Transcriptomic analysis of senescent cells treated with Cardiac glycosides

Project description:IMR90 ER:RAS cells were treated with 4OHT to induce senescence. 6 days later they were treated with Vehicle, Ouabain or Digoxin for 16 or 36h and collected he cells were collected for total mRNA analysis. Minus (Cell not treated with 4OHT), Plus (Cell treated with 4OHT and vehicle), Plus C (On to pof the aforementiones treatments, cells were treated with Caspase inhibitors O/N)

2019-09-03 | GSE122079 | GEO

Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells

2012-04-04 | GSE35126 | GEO

Proteomic analysis of GC7-treated senescent and proliferating BJ fibroblasts

Project description:Quantitative analysis of global proteomic changes in proliferating and senescent BJ fibroblasts, treated with eIF5A hypusination inhibitor GC7 (10 uM) for 12h.

2024-07-12 | PXD034251 | Pride

Nascent proteome analysis of proliferating and senescent BJ fibroblast treated with GC7

Project description:Analysis of proteomic changes in proliferating and senescent BJ fibroblast treated with eIF5A hypusination inhibitor GC7 for 12h.

2024-07-12 | PXD034334 | Pride

Transcriptomic analysis of senescent cells and liver treated with Cardiac glycosides

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-09-03 | GSE122081 | GEO